Prelude Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,013
Closed -$249K 1825
2022
Q3
$249K Sell
1,013
-1,830
-64% -$494K 0.01% 966
2022
Q2
$704K Buy
+2,843
New +$767K 0.02% 655
2020
Q3
Sell
-262
Closed -$75.5K 2520
2020
Q2
$63K Buy
+262
New +$52.6K ﹤0.01% 1104
2020
Q1
Sell
-565
Closed -$96K 2194
2019
Q4
$96K Buy
+565
New +$105K ﹤0.01% 1122
2019
Q2
Sell
-156
Closed -$45K 2267
2019
Q1
$45K Sell
156
-381
-71% -$127K ﹤0.01% 1152
2018
Q4
$175K Buy
+537
New +$187K 0.01% 769
2018
Q3
Sell
-38
Closed -$16K 2136
2018
Q2
$16K Sell
38
-374
-91% -$135K ﹤0.01% 1398
2018
Q1
$120K Sell
412
-209
-34% -$53K 0.01% 823
2017
Q4
$116K Buy
621
+16
+3% +$2.99K 0.01% 754
2017
Q3
$102K Sell
605
-109
-15% -$16.5K 0.01% 873
2017
Q2
$102K Buy
+714
New +$96K 0.01% 772
2016
Q4
Sell
-607
Closed -$78K 1854
2016
Q3
$78K Buy
607
+20
+3% +$2.4K 0.01% 906
2016
Q2
$64K Buy
+587
New +$58.4K 0.01% 915
2015
Q2
Sell
-1,427
Closed -$102K 2137
2015
Q1
$102K Buy
1,427
+127
+10% +$6.89K 0.01% 998
2014
Q4
$49K Hold
1,300
0.01% 1249
2014
Q3
$32K Hold
1,300
﹤0.01% 1623
2014
Q2
$33K Hold
1,300
﹤0.01% 1613
2014
Q1
$34K Hold
1,300
﹤0.01% 1528
2013
Q4
$35K Buy
+1,300
New +$32.1K 0.01% 1216

Other funds holding ABMD

Prelude Capital Management's ABMD Position: Q4 2022 in Review

Prelude Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,013 shares — an estimated $249K sold.

Prelude Capital Management first reported a position in ABMD in Q4 2013 and held it in 19 quarters. The position peaked at $704K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Prelude Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 1,013 Abiomed Inc shares in Q4 2022, an estimated $249K.
  • Prelude Capital Management first reported a position in Abiomed Inc in Q4 2013 and held it in 19 quarters.
  • Prelude Capital Management's Abiomed Inc position peaked at $704K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.